Gilles Fénelon

Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors

Gilles Fénelon · Brain · 2000 · 1K citations

Neuropsychology, Corticobasal Degeneration, Neuropsychiatry +17

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

Stéphane Palfi, Jean Marc Gurruchaga, G. Ralph et al. · The Lancet · 2014 · 432 citations

Gene Therapies, Neurodegenerative Diseases, Dose Escalation +11

The primate motor thalamus

G. Percheron, C. François, B. Talbi et al. · Brain Research Reviews · 1996 · 221 citations

Neural Mechanism, Neuroanatomy, Motor System +9

The changing face of Parkinson's disease‐associated psychosis: A cross‐sectional study based on the new NINDS‐NIMH criteria

Gilles Fénelon, Thierry Soulas, Franck Zenasni et al. · Movement Disorders · 2010 · 213 citations · Full text

Psychiatric Disorders, Corticobasal Degeneration, Neuropsychiatry +21

Scales to assess psychosis in Parkinson's disease: Critique and recommendations

Hubert H. Fernandez, Dag Aarsland, Gilles Fénelon et al. · Movement Disorders · 2008 · 184 citations